ID: 3521058 CONTINUATION OF LOW DOSE ASPIRIN DURING PERI-GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION PERIOD AND INCREASED BLEEDING RISK: A RANDOMIZED NON-INFERIORITY TRIAL

Kohei Takizawa,Noriya Uedo,Takuji Gotoda,Takuji Akamatsu,Hisashi Doyama,Osamu Dohi,Koichi Kawabe,Shoichi Kayaba,Yoshimasa Miura,Hiroya Mizutani,Haruhisa Suzuki,Satoshi Ono,Tatsuya Mikami,Hideki Ishikawa
DOI: https://doi.org/10.1016/j.gie.2021.03.851
IF: 10.396
2021-01-01
Gastrointestinal Endoscopy
Abstract:Current Japanese Gastroenterological Endoscopy Society (JGES) guideline recommend interrupting low-dose aspirin (LDA) during peri-procedural period of endoscopic submucosal dissection (ESD) for early gastric cancer in low thrombotic risk patients. However, if continuation of LDA during peri-ESD period does not increase bleeding risk related to the procedure significantly, gastric ESD can be performed under sustained anti-thrombotic effect of LDA.
What problem does this paper attempt to address?